<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01515072</url>
  </required_header>
  <id_info>
    <org_study_id>0120110125</org_study_id>
    <nct_id>NCT01515072</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Preconditioning in Neurological Death Organ Donors</brief_title>
  <acronym>RIPNOD</acronym>
  <official_title>Remote Ischemic Preconditioning in Neurological Death Organ Donors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Health Resources and Services Administration (HRSA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Health Science Center at San Antonio</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether application of lower limb remote ischemic
      preconditioning (RIPC) after determination of brain death improves donor stability, organ
      quality, organ yield, and early post transplant clinical outcomes.

      Neurological death donors will be stratified into standard and extended criteria donors
      (SCD/ECD) and randomized in a 1:1 fashion to RIPC or No intervention. The primary outcome is
      the number of organs recovered per donor. Secondary outcomes include donor hemodynamic state,
      donor organ-specific function parameters, pulsatile perfusion parameters, number of organs
      transplanted per donor, recipient hospital free survival and delayed graft function of
      kidneys. The sample size is powered to detect a difference of 0.44 organs recovered.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Design and Participants The RIPNOD trial was conducted from July 2011 to July 2014 as a
      prospective randomized trial in two OPOs (in New Jersey and in Texas) in the U.S. The funding
      organization, institutional review boards and the physician committees of the two organ
      procurement organizations (OPOs) approved the study. Exemptions for consent from potential
      recipients and for a data and safety monitoring board were granted. Consent for research was
      obtained from the donor's next of kin by OPO staff unless a 'first-person' consent existed.
      The study population consisted of neurological death organ donors. Eligible donors were age &gt;
      6 years, in whom death declaration was either imminent or completed, and organ recovery was
      not expected within 6 hours of enrollment. Donors with severe trauma to lower extremity or on
      sulfonylurea agents were excluded (Trial Protocol in Supplement).

      Procedures Randomization (1:1) to No RIPC or RIPC groups in standard and extended criteria
      donors (SCD and ECD) strata occurred based on a computer-generated random table of numbers.
      In Texas, field coordinators performed the randomization through a website and administered
      the intervention. In New Jersey, research staff performed all trial activities and randomized
      using opaque, sealed envelopes. Organ recovery teams were informed of the study and sometimes
      knew of the group assignment. The recipient care teams and recipients were not aware of the
      group assignment.

      The intervention consisted of four cycles of inflation of a tourniquet around mid-thigh to
      250 mm Hg for 5 minutes followed by 5 minutes of deflation. The initial intervention occurred
      in the right thigh as early as possible after declaration of death. The second intervention
      occurred in the left thigh 24 hours after the initial intervention, or immediately before
      recovery, if this was earlier. Videoconferences between the two sites helped standardize the
      intervention before the trial commenced. All decisions regarding donor management, organ
      recovery, machine perfusion of kidneys, transplantation of organs and care after
      transplantation were independent of the research teams.

      Outcomes and Data Collection The primary outcome was the total number of organs recovered per
      donor. Secondary outcomes were number of organs transplanted per donor, and changes from
      baseline to terminal (before aortic cross clamp) in vasopressor support, serum lactate,
      creatinine clearance, left ventricular ejection fraction, serum troponins, partial pressure
      of arterial oxygen: fraction inspired oxygen (P:F) ratio, dynamic and static lung compliance,
      and perfusate flow and resistance in machine perfused kidneys, delayed graft function (DGF)
      in transplanted kidneys and six-month hospital free survival in all recipients. A score
      quantified vasopressor support.14 All laboratory tests were performed at donor hospitals.
      Cockcroft-Gault equation was used to calculate creatinine clearance.15 Donor hospital
      cardiologists estimated the ventricular ejection fraction in transthoracic echocardiograms.
      OPO policies dictated machine perfusion of kidneys; perfusion, occurred at a central location
      in each OPO. Delayed graft function was defined as dialysis in the first week after
      transplant. Six month hospital-free survival was defined as the number of days recipients
      survived following the initial discharge after the transplant. All donor data were obtained
      prospectively from OPO records. Data after transplantation were obtained from the Scientific
      Registry of Transplant Recipients (SRTR). The SRTR data system includes data on all donors,
      waitlist candidates, and transplant recipients in the United States, submitted by members of
      the Organ Procurement and Transplantation Network (OPTN). The Health Resources and Services
      Administration (HRSA), U.S. Department of Health and Human Services provides oversight to the
      activities of the OPTN and SRTR contractors.

      Sample Size A sample size of 150 donors in each arm was estimated to provide 80% power to
      detect a difference of 0.44 of an organ recovered and 0.48 of an organ transplanted per
      donor. The difference criterion was chosen based on published results achieved with hormonal
      resuscitation in organ donors. 6 Pooled standard deviations (organs recovered: 1.35; organs
      transplanted: 1.5) from data of two OPOs were used.

      Statistical Analyses Intention to treat principle was used in all analyses. Discrete
      descriptive data are reported as counts and percent and continuous data as means (sd) or
      medians (interquartile range). Continuous variables were compared using either t, or
      equivalent non-parametric tests. Categorical variables were compared using chi square tests.
      Multivariate modeling with backward elimination - linear ones to model RIPC on recovery and
      transplantation of all (0-8) and abdominal organs (0-5) per donor, and logistic ones to model
      recovery/transplantation of &gt; 1 thoracic organ per donor and DGF - was performed. Because
      only seven fewer thoracic organs were transplanted than recovered the model for organs
      transplanted was used to analyze both outcomes. Donor characteristics of age, sex, race,
      cause of death, BMI, comorbidities (hypertension, diabetes, alcohol use, and hepatitis C),
      treatments (insulin, diuretics and steroids) and laboratory parameters (serum creatinine and
      P:F ratio) and OPO site were predictor variables in organ yield models. Donor age or stratum,
      cold ischemia, number of human leukocyte antigen mismatches and recipients' characteristics
      of age, sex, race, BMI, diabetes, hypertension, etiology of renal failure, panel reactive
      antibody and OPO site were predictor variables in models of DGF. For linear regression
      models, adjusted R2 was computed and residuals were assessed for normality; the C statistic
      was used to assess goodness of the fit for logistic regression. Statistical significance was
      set at p&lt;0.05.

      Post Hoc Analyses Rates of acute rejection of kidney during the first six months were
      compared between the two groups using chi square tests. Kaplan-Meier estimates and log rank
      tests were used to compare unadjusted outcomes of graft and patient survival at 6, 12 and 24
      months. In heart, lung and liver recipients, retransplantation or death was defined as graft
      loss. In all other organs graft loss was death-censored. Cox proportional hazards models were
      used to estimate the effect of RIPC on the adjusted hazard ratio for six-month graft loss
      after controlling for OPO site, donor age or stratum and sex, cold ischemia time, number of
      antigen mismatches, organ transplanted, and recipient age, sex, race, BMI, diabetes and
      hypertension.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Organs Recovered Per Donor</measure>
    <time_frame>At time of organ recovery, up to 1 day</time_frame>
    <description>Number of organs recovered per organ donor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Organs Transplanted Per Donor</measure>
    <time_frame>Within 24 hours of organ recovery</time_frame>
    <description>Number of organs transplanted from each organ donor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Vasopressor Score</measure>
    <time_frame>Vasopressor score was determined before aortic cross clamp minus the value prior to the first intervention, an average of 19 hours</time_frame>
    <description>Changes in the following: Vasopressor usage, serum Lactate, Creatinine clearance, arterial oxygen pressure:fraction of inspired oxygen (P:F) ratios, Lung Compliance, Cardiac biomarkers, ejection fraction (EF) from 2-dimensional Echocardiogram.
Here we will present data for the change in vasopressor use evaluated using a vasopressor score.
A numerical score calculated for number and dose of Vasopressors in use. The score is calculated using the following formula (from Zuppa AF et. al.CRIT CARE MED 2004 Vol. 32 p 2318-2322):
Vasopressor Score= (dopamine dose[y=ug/kg/min x 1]) + (dobutamine dose [ug/kg/min] x 1) + (epinephrine dose [ug/kg/min] x100) + (norepinephrine dose [ug/kg/min] x 100) + (phenylephrine dose [ug/kg/min] x 100).
The range for our study was 0-4900 with higher doses indicating higher vasopressor use in the donor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Serum Lactate</measure>
    <time_frame>Subjects will be followed from admission to explantation, an average of 4.5 days</time_frame>
    <description>Change in serum lactate levels (mg/dL) from before intervention to the final value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Creatinine Clearance</measure>
    <time_frame>Subjects will be followed from admission to explantation, an average of 4.5 days</time_frame>
    <description>Change in creatinine clearance (mL/min by Cockcroft-Gault method) from before intervention to terminal value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in P:F Ratio</measure>
    <time_frame>Subjects will be followed from admission to explantation, an average of 4.5 days</time_frame>
    <description>Change in ratio of arterial oxygen pressure:fraction inspired oxygen ratio from before intervention to terminal value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Dynamic Compliance</measure>
    <time_frame>Subjects will be followed from admission to explantation, an average of 4.5 days</time_frame>
    <description>Change in dynamic compliance of the lung from before intervention to terminal value
Cdyn = Dynamic compliance; Vt = tidal volume; PIP = Peak inspiratory pressure (the maximum pressure during inspiration); PEEP = Positive End Expiratory Pressure:
Cdyn= Vt/PIP - PEEP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Troponins</measure>
    <time_frame>Subjects will be followed from admission to explantation, an average of 4.5 days</time_frame>
    <description>Change in serum troponin I (ng/mL) from before intervention to terminal value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulsatile Perfusion Flow</measure>
    <time_frame>Up to 24 hours of machine perfusion</time_frame>
    <description>Perfusate flow (mL/min) in machine perfused kidneys.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six Month Hospital Free Survival of All Organ Recipients</measure>
    <time_frame>6 months post-transplant</time_frame>
    <description>Six month hospital-free survival was defined as the number of days recipients survived following the initial discharge after the transplant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delayed Graft Function (DGF) of Kidney Recipients.</measure>
    <time_frame>7 days post-transplant</time_frame>
    <description>DGF is defined as the need for dialysis within the first week post transplantation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulsatile Perfusion Parameters</measure>
    <time_frame>Up to 24 hours of machine perfusion</time_frame>
    <description>Perfusate resistance (mm Hg/mL/min) in machine perfused kidneys.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">321</enrollment>
  <condition>Organ Transplantation</condition>
  <arm_group>
    <arm_group_label>No Remote Ischemic Preconditioning</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remote Ischemic Preconditioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>RIPC (Remote Ischemic Preconditioning)</intervention_name>
    <description>Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
    <arm_group_label>Remote Ischemic Preconditioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Neurological death donors in whom brain death determination is imminent

          2. First person consent or next of kin consent for research

          3. Donors &gt;=6 years of age

          4. Organ recovery not expected within 6 hours of consent.

          5. Both sexes and ethnicities.

        Exclusion Criteria:

          1. Donation after cardiac death donors (DCD)

          2. Live organ donors

          3. No first person consent and next of kin decline research consent

          4. Donor Age &lt; 6 years

          5. Lower extremity trauma or recent amputation

          6. Tissue only donors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Baburao Koneru, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Medicine and Dentistry New Jersey-Newark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William K Washburn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Health Sciences at San Antonio</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rutgers, The State University of New Jersey</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2011</study_first_submitted>
  <study_first_submitted_qc>January 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2012</study_first_posted>
  <results_first_submitted>April 28, 2016</results_first_submitted>
  <results_first_submitted_qc>April 6, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 20, 2017</results_first_posted>
  <last_update_submitted>April 6, 2017</last_update_submitted>
  <last_update_submitted_qc>April 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Remote Ischemic Preconditioning</keyword>
  <keyword>Brain death organ donors</keyword>
  <keyword>Delayed graft function</keyword>
  <keyword>Donor management</keyword>
  <keyword>Pulsatile perfusion</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The RIPNOD trial was conducted from July 2011 to July 2014 in two organ procurement organizations (OPO) in the U.S. Consent for research was obtained from donors next of kin by the OPO staff unless a 'first person' consent existed.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>No RIPC</title>
          <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
        </group>
        <group group_id="P2">
          <title>RIPC</title>
          <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="166"/>
                <participants group_id="P2" count="155"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="166">There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.</participants>
                <participants group_id="P2" count="155">There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All donors enrolled in both groups were included in the in-between group comparisons of baseline characteristics</population>
      <group_list>
        <group group_id="B1">
          <title>No RIPC</title>
          <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
        </group>
        <group group_id="B2">
          <title>RIPC</title>
          <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="166"/>
            <count group_id="B2" value="155"/>
            <count group_id="B3" value="321"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44" lower_limit="29" upper_limit="54"/>
                    <measurement group_id="B2" value="42" lower_limit="29" upper_limit="51"/>
                    <measurement group_id="B3" value="43" lower_limit="29" upper_limit="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>11-25</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>26-35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>36-45</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>46-75</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="121"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="107"/>
                    <measurement group_id="B2" value="93"/>
                    <measurement group_id="B3" value="200"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African-American</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="166"/>
                    <measurement group_id="B2" value="155"/>
                    <measurement group_id="B3" value="321"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <description>2 Categories &lt; 30.0
=/&gt; 30.0</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>BMI &lt; 30.0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="104"/>
                    <measurement group_id="B3" value="230"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BMI =/&gt; 30.0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hepatitis C Antibody</title>
          <description>Serological test for Hepatitis C antibody:
Yes or No</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="159"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="298"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Co-Morbidities</title>
          <description>Hypertension: Yes or No</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hypertension: Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertension: No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="108"/>
                    <measurement group_id="B2" value="107"/>
                    <measurement group_id="B3" value="215"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Central Line Use</title>
          <description>Donors who had Central line in place: Yes or No</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="121"/>
                    <measurement group_id="B2" value="116"/>
                    <measurement group_id="B3" value="237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Co-Morbidities</title>
          <description>Diabetes: Yes or No</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Diabetes: Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes: No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="147"/>
                    <measurement group_id="B2" value="134"/>
                    <measurement group_id="B3" value="281"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Co-Morbidities</title>
          <description>Past or Current Smoker: Yes or No</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Past or Current Smoker:Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                    <measurement group_id="B2" value="99"/>
                    <measurement group_id="B3" value="188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Past or Current Smoker:No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="133"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Steroids Administered</title>
          <description>Steroids Administered: Yes or No</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Steroids Administered: Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="122"/>
                    <measurement group_id="B3" value="247"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Steroids Administered: No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Insulin Infusion</title>
          <description>Insulin Infusion: Yes or No</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Insulin Infusion: Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Insulin Infusion: No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="113"/>
                    <measurement group_id="B3" value="232"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Declaration of Death to Initial Intervention, Hours</title>
          <description>Interval from declaration of brain death to the initial intervention.</description>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.8" lower_limit="4.2" upper_limit="8.8"/>
                    <measurement group_id="B2" value="7.3" lower_limit="5.0" upper_limit="12.1"/>
                    <measurement group_id="B3" value="6.5" lower_limit="4.7" upper_limit="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Initial Intervention to Cross Clamp</title>
          <description>3 Groups:
5.9-24.0 hours
24.1-39.5 hours
Data Not Available</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Intervention to Cross Clamp: 5.9-24.0 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="123"/>
                    <measurement group_id="B2" value="115"/>
                    <measurement group_id="B3" value="238"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intervention to Cross Clamp: 24.1-39.5 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intervention to Cross Clamp: Data not available</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Vasopressor Score</title>
          <description>A numerical score calculated for number and dose of Vasopressors in use. The score is calculated using the following formula (from Zuppa AF et. al.CRIT CARE MED 2004 Vol. 32 p 2318-2322):
Vasopressor Score= (dopamine dose[y=ug/kg/min x 1]) + (dobutamine dose [ug/kg/min] x 1) + (epinephrine dose [ug/kg/min] x100) + (norepinephrine dose [ug/kg/min] x 100) + (phenylephrine dose [ug/kg/min] x 100).
The range for our study was 0-4900 with higher doses indicating higher vasopressor use in the donor.
Data missing per group:
No RIPC=2 RIPC=2</description>
          <population>Data missing for 2 participants in each arm of the study.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="164"/>
                    <count group_id="B2" value="153"/>
                    <count group_id="B3" value="317"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="100" lower_limit="0" upper_limit="925.0"/>
                    <measurement group_id="B2" value="16.0" lower_limit="0" upper_limit="600"/>
                    <measurement group_id="B3" value="37" lower_limit="0" upper_limit="800"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>P:F ratio</title>
          <description>P:F ratio: Ratio of partial pressure of arterial oxygen: fraction of inspired oxygen.
Missing data:
No RIPC=2 RIPC=4</description>
          <units>ratio</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="249.8" lower_limit="154.8" upper_limit="393.0"/>
                    <measurement group_id="B2" value="244.0" lower_limit="152.0" upper_limit="387.5"/>
                    <measurement group_id="B3" value="248" lower_limit="154.3" upper_limit="389.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ventricular Ejection Fraction</title>
          <description>Ventricular Ejection Fraction
Missing data:
No RIPC: 39 RIPC: 31</description>
          <units>proportion ejection fraction</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.6" lower_limit="0.55" upper_limit="0.65"/>
                    <measurement group_id="B2" value="0.59" lower_limit="0.49" upper_limit="0.65"/>
                    <measurement group_id="B3" value="0.6" lower_limit="0.52" upper_limit="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Serum Chemistry: Creatinine</title>
          <description>Serum Chemistry: Creatinine, mg/dL
Missing data:
No RIPC=3 RIPC=2</description>
          <units>mg/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.0" lower_limit="0.7" upper_limit="1.6"/>
                    <measurement group_id="B2" value="1.1" lower_limit="0.8" upper_limit="1.4"/>
                    <measurement group_id="B3" value="1.06" lower_limit="0.8" upper_limit="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Serum Chemistry: Lactate</title>
          <description>Serum Chemistry: Lactate, mg/dL
Missing data:
No RIPC= 31 RIPC= 21</description>
          <units>mg/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.5" lower_limit="1.1" upper_limit="2.4"/>
                    <measurement group_id="B2" value="1.6" lower_limit="1.1" upper_limit="2.4"/>
                    <measurement group_id="B3" value="1.6" lower_limit="1.1" upper_limit="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Serum Chemistry: Troponin I</title>
          <description>Serum Chemistry: Troponin I, ng/ml
Missing data:
No RIPC= 37 RIPC= 29</description>
          <units>ng/ml</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="166"/>
                    <count group_id="B2" value="155"/>
                    <count group_id="B3" value="321"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.28" lower_limit="0.04" upper_limit="1.07"/>
                    <measurement group_id="B2" value="0.31" lower_limit="0.07" upper_limit="1.25"/>
                    <measurement group_id="B3" value="0.29" lower_limit="0.05" upper_limit="1.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Organs Recovered Per Donor</title>
        <description>Number of organs recovered per organ donor</description>
        <time_frame>At time of organ recovery, up to 1 day</time_frame>
        <population>Subjects were organ donors enrolled in this multicenter study</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Organs Recovered Per Donor</title>
          <description>Number of organs recovered per organ donor</description>
          <population>Subjects were organ donors enrolled in this multicenter study</population>
          <units>organs recovered per donor</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="166"/>
                <count group_id="O2" value="155"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.79" spread="1.73"/>
                    <measurement group_id="O2" value="3.60" spread="1.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Sample Size and Power estimation: A sample size of at least 150 donors in each arm was estimated to provide 80% power to detect a difference of 0.44 of an organ recovered and 0.48 of an organ transplanted per donor. The difference criterion was chosen based on published results achieved with hormonal resuscitation in organ donors. 6 Pooled standard deviations (organs recovered: 1.35; organs transplanted: 1.5) from data of two OPOs were used.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.38</p_value>
            <p_value_desc>This is an unadjusted comparison. P value &lt; 0.05</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>Adjusted analyses for the RIPC effect are provided below.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.37</ci_lower_limit>
            <ci_upper_limit>0.21</ci_upper_limit>
            <estimate_desc>0.08 less organs per donor in the RIPC group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Organs Transplanted Per Donor</title>
        <description>Number of organs transplanted from each organ donor</description>
        <time_frame>Within 24 hours of organ recovery</time_frame>
        <population>Subjects were organ donors enrolled in this multicenter study</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Organs Transplanted Per Donor</title>
          <description>Number of organs transplanted from each organ donor</description>
          <population>Subjects were organ donors enrolled in this multicenter study</population>
          <units>Organs transplanted from each donor</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="166"/>
                <count group_id="O2" value="155"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.41" spread="1.90"/>
                    <measurement group_id="O2" value="3.31" spread="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Sample Size A sample size of at least 150 donors in each arm was estimated to provide 80% power to detect a difference of 0.44 of an organ recovered and 0.48 of an organ transplanted per donor. The difference criterion was chosen based on published results achieved with hormonal resuscitation in organ donors. 6 Pooled standard deviations (organs recovered: 1.35; organs transplanted: 1.5) from data of two OPOs were used.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.70</p_value>
            <p_value_desc>This is an unadjusted analysis. P &lt; 0.05</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>Adjusted analyses are provided below.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.33</ci_lower_limit>
            <ci_upper_limit>0.26</ci_upper_limit>
            <estimate_desc>0.03 less organs per donor in the RIPC group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Vasopressor Score</title>
        <description>Changes in the following: Vasopressor usage, serum Lactate, Creatinine clearance, arterial oxygen pressure:fraction of inspired oxygen (P:F) ratios, Lung Compliance, Cardiac biomarkers, ejection fraction (EF) from 2-dimensional Echocardiogram.
Here we will present data for the change in vasopressor use evaluated using a vasopressor score.
A numerical score calculated for number and dose of Vasopressors in use. The score is calculated using the following formula (from Zuppa AF et. al.CRIT CARE MED 2004 Vol. 32 p 2318-2322):
Vasopressor Score= (dopamine dose[y=ug/kg/min x 1]) + (dobutamine dose [ug/kg/min] x 1) + (epinephrine dose [ug/kg/min] x100) + (norepinephrine dose [ug/kg/min] x 100) + (phenylephrine dose [ug/kg/min] x 100).
The range for our study was 0-4900 with higher doses indicating higher vasopressor use in the donor.</description>
        <time_frame>Vasopressor score was determined before aortic cross clamp minus the value prior to the first intervention, an average of 19 hours</time_frame>
        <population>Donors in whom vasopressor agent and dose were described in the OPO records before intervention and prior to aortic cross clamp.</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Vasopressor Score</title>
          <description>Changes in the following: Vasopressor usage, serum Lactate, Creatinine clearance, arterial oxygen pressure:fraction of inspired oxygen (P:F) ratios, Lung Compliance, Cardiac biomarkers, ejection fraction (EF) from 2-dimensional Echocardiogram.
Here we will present data for the change in vasopressor use evaluated using a vasopressor score.
A numerical score calculated for number and dose of Vasopressors in use. The score is calculated using the following formula (from Zuppa AF et. al.CRIT CARE MED 2004 Vol. 32 p 2318-2322):
Vasopressor Score= (dopamine dose[y=ug/kg/min x 1]) + (dobutamine dose [ug/kg/min] x 1) + (epinephrine dose [ug/kg/min] x100) + (norepinephrine dose [ug/kg/min] x 100) + (phenylephrine dose [ug/kg/min] x 100).
The range for our study was 0-4900 with higher doses indicating higher vasopressor use in the donor.</description>
          <population>Donors in whom vasopressor agent and dose were described in the OPO records before intervention and prior to aortic cross clamp.</population>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-15.60" lower_limit="-600" upper_limit="0"/>
                    <measurement group_id="O2" value="-6.00" lower_limit="-400" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.63</p_value>
            <p_value_desc>P&lt;0.05</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>This is an unadjusted comparison</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Serum Lactate</title>
        <description>Change in serum lactate levels (mg/dL) from before intervention to the final value</description>
        <time_frame>Subjects will be followed from admission to explantation, an average of 4.5 days</time_frame>
        <population>Donors in whom at least two serum lactate levels (one before and one after the initial intervention) were available</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Serum Lactate</title>
          <description>Change in serum lactate levels (mg/dL) from before intervention to the final value</description>
          <population>Donors in whom at least two serum lactate levels (one before and one after the initial intervention) were available</population>
          <units>mg/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="127"/>
                <count group_id="O2" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" lower_limit="-40" upper_limit="0.70"/>
                    <measurement group_id="O2" value="0.20" lower_limit="-40" upper_limit="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.86</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Creatinine Clearance</title>
        <description>Change in creatinine clearance (mL/min by Cockcroft-Gault method) from before intervention to terminal value</description>
        <time_frame>Subjects will be followed from admission to explantation, an average of 4.5 days</time_frame>
        <population>Donors in whom two serum creatinine values (one before intervention and another after the initial intervention) are available.</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Creatinine Clearance</title>
          <description>Change in creatinine clearance (mL/min by Cockcroft-Gault method) from before intervention to terminal value</description>
          <population>Donors in whom two serum creatinine values (one before intervention and another after the initial intervention) are available.</population>
          <units>mL/min</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="155"/>
                <count group_id="O2" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-8.1" upper_limit="9.8"/>
                    <measurement group_id="O2" value="0" lower_limit="-10.6" upper_limit="14.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.55</p_value>
            <p_value_desc>P&lt;0.05</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>This is an unadjusted comparison</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in P:F Ratio</title>
        <description>Change in ratio of arterial oxygen pressure:fraction inspired oxygen ratio from before intervention to terminal value</description>
        <time_frame>Subjects will be followed from admission to explantation, an average of 4.5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.
Any discrepancy in the number of participants is attributed to missing data for some participants</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first occurs immediately after brain death declaration and consent for organ donation. The second one immediately before of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention occurs at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.
Any discrepancy in the number of participants is attributed to missing data for some participants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in P:F Ratio</title>
          <description>Change in ratio of arterial oxygen pressure:fraction inspired oxygen ratio from before intervention to terminal value</description>
          <units>ratio</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="152"/>
                <count group_id="O2" value="142"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" lower_limit="-57.3" upper_limit="86.5"/>
                    <measurement group_id="O2" value="0.05" lower_limit="-74.3" upper_limit="96.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.55</p_value>
            <p_value_desc>P&lt;0.05</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>This is an unadjusted comparison</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Dynamic Compliance</title>
        <description>Change in dynamic compliance of the lung from before intervention to terminal value
Cdyn = Dynamic compliance; Vt = tidal volume; PIP = Peak inspiratory pressure (the maximum pressure during inspiration); PEEP = Positive End Expiratory Pressure:
Cdyn= Vt/PIP - PEEP</description>
        <time_frame>Subjects will be followed from admission to explantation, an average of 4.5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.
Any discrepancy in the number of participants is attributed to missing data for some participants</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first occurs immediately after brain death declaration and consent for organ donation. The second one immediately before of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention occurs at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.
Any discrepancy in the number of participants is attributed to missing data for some participants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Dynamic Compliance</title>
          <description>Change in dynamic compliance of the lung from before intervention to terminal value
Cdyn = Dynamic compliance; Vt = tidal volume; PIP = Peak inspiratory pressure (the maximum pressure during inspiration); PEEP = Positive End Expiratory Pressure:
Cdyn= Vt/PIP - PEEP</description>
          <units>L/cm H20</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="123"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.30" lower_limit="-2.0" upper_limit="7.6"/>
                    <measurement group_id="O2" value="1.20" lower_limit="-1.8" upper_limit="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.48</p_value>
            <p_value_desc>P&lt;0.05</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>This is an unadjusted comparison</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Troponins</title>
        <description>Change in serum troponin I (ng/mL) from before intervention to terminal value</description>
        <time_frame>Subjects will be followed from admission to explantation, an average of 4.5 days</time_frame>
        <population>Only donors in whom two troponin I values (one before intervention and another after the initial intervention) were available were included in this analysis</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Troponins</title>
          <description>Change in serum troponin I (ng/mL) from before intervention to terminal value</description>
          <population>Only donors in whom two troponin I values (one before intervention and another after the initial intervention) were available were included in this analysis</population>
          <units>ng/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="122"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" lower_limit="-0.38" upper_limit="0"/>
                    <measurement group_id="O2" value="-0.09" lower_limit="-0.69" upper_limit="-0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <p_value_desc>P&lt;0.05</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>This is an unadjusted comparison</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pulsatile Perfusion Flow</title>
        <description>Perfusate flow (mL/min) in machine perfused kidneys.</description>
        <time_frame>Up to 24 hours of machine perfusion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>Kidneys in this group were recovered from donors in the No RIPC arm. Decisions regarding which kidneys were not and were pumped were made by the OPO.
Any discrepancy in the number of participants is attributed to missing data for some subjects.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>Kidneys in this group were recovered from donors in the RIPC arm. Decisions regarding which kidneys were not and were pumped were made by the OPO.
Any discrepancy in the number of participants is attributed to missing data for some subjects.</description>
          </group>
        </group_list>
        <measure>
          <title>Pulsatile Perfusion Flow</title>
          <description>Perfusate flow (mL/min) in machine perfused kidneys.</description>
          <units>mL/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Flow at 1 hour, mL/min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.58" spread="32.41"/>
                    <measurement group_id="O2" value="89.42" spread="38.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.28" spread="23.75"/>
                    <measurement group_id="O2" value="104.03" spread="40.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="117.98" spread="28.86"/>
                    <measurement group_id="O2" value="94.21" spread="32.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115.19" spread="20.07"/>
                    <measurement group_id="O2" value="106.36" spread="32.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.53</p_value>
            <p_value_desc>P&lt;0.05</p_value_desc>
            <method>Regression, Linear</method>
            <method_desc>Final flow was modeled on RIPC and adjusted for donor stratum and duration of perfusion</method_desc>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>-4.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-10.1</ci_lower_limit>
            <ci_upper_limit>19.5</ci_upper_limit>
            <estimate_desc>Data shown above is the the adjusted mean difference in final flow in RIPC group</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Six Month Hospital Free Survival of All Organ Recipients</title>
        <description>Six month hospital-free survival was defined as the number of days recipients survived following the initial discharge after the transplant.</description>
        <time_frame>6 months post-transplant</time_frame>
        <population>Recipients of all organs from donors enrolled in the two arms</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Six Month Hospital Free Survival of All Organ Recipients</title>
          <description>Six month hospital-free survival was defined as the number of days recipients survived following the initial discharge after the transplant.</description>
          <population>Recipients of all organs from donors enrolled in the two arms</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="482"/>
                <count group_id="O2" value="456"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="172" lower_limit="165" upper_limit="174"/>
                    <measurement group_id="O2" value="171" lower_limit="165" upper_limit="174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.97</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Delayed Graft Function (DGF) of Kidney Recipients.</title>
        <description>DGF is defined as the need for dialysis within the first week post transplantation.</description>
        <time_frame>7 days post-transplant</time_frame>
        <population>Kidney recipients of donors in each arm.</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Delayed Graft Function (DGF) of Kidney Recipients.</title>
          <description>DGF is defined as the need for dialysis within the first week post transplantation.</description>
          <population>Kidney recipients of donors in each arm.</population>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>Kidney Recipients</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="166"/>
                <count group_id="O2" value="155"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Kidney Recipients</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="247"/>
                <count group_id="O2" value="235"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>DGF: Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DGF: No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="202"/>
                    <measurement group_id="O2" value="184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.07</p_value>
            <p_value_desc>Adjusted analysis with recipient age as a continuous variable, sex, race as black versus not black, body mass index, diabetes, hypertension,antigen mismatches, donor age as a continuous variable and trial site.</p_value_desc>
            <method>Chi-squared</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.62</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.95</ci_lower_limit>
            <ci_upper_limit>2.76</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.36</p_value>
            <p_value_desc>Unadjusted analysis</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pulsatile Perfusion Parameters</title>
        <description>Perfusate resistance (mm Hg/mL/min) in machine perfused kidneys.</description>
        <time_frame>Up to 24 hours of machine perfusion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Remote Ischemic Preconditioning</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>Remote Ischemic Preconditioning</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Pulsatile Perfusion Parameters</title>
          <description>Perfusate resistance (mm Hg/mL/min) in machine perfused kidneys.</description>
          <units>Resistance, mm Hg/mL/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Resistance at 1 hour, mL/min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.12"/>
                    <measurement group_id="O2" value="0.38" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Resistance at 4 hours, mL/min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="0.10"/>
                    <measurement group_id="O2" value="0.31" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Resistance at 8 hours, mL/min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.22" spread="0.09"/>
                    <measurement group_id="O2" value="0.33" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Resistance at 12 hours, mL/min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.22" spread="0.08"/>
                    <measurement group_id="O2" value="0.29" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.006</p_value>
            <method>Regression, Linear</method>
            <method_desc>Final resistance was modeled on RIPC and adjusted for donor stratum and duration of perfusion.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.03</ci_lower_limit>
            <ci_upper_limit>0.17</ci_upper_limit>
            <estimate_desc>Data shown above is the adjusted mean difference in final resistance in the RIPC group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Acute Kidney Rejection</title>
        <description>Diagnosis of rejection as documented in the recipient records in the Scientific Registry of Transplant Recipients (SRTR).</description>
        <time_frame>6 months after kidney transplantation</time_frame>
        <population>This outcome was examined in recipients of in SRTR that received kidneys from donors in the RIPNOD trial</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Acute Kidney Rejection</title>
          <description>Diagnosis of rejection as documented in the recipient records in the Scientific Registry of Transplant Recipients (SRTR).</description>
          <population>This outcome was examined in recipients of in SRTR that received kidneys from donors in the RIPNOD trial</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="247"/>
                <count group_id="O2" value="235"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rejection: Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rejection: No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="230"/>
                    <measurement group_id="O2" value="222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.50</p_value>
            <method>Fisher Exact</method>
            <method_desc>This is an unadjusted comparison</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Graft Survival</title>
        <description>Kaplan-Meier estimates of 6, 12 and 24 months survival of all grafts</description>
        <time_frame>Graft survival was monitored from transplant date until retransplantation or death up to 2 years as in SRTR data file October 2015</time_frame>
        <population>All grafts transplanted from donors in the RIPNOD trial and in whom recipient records are available in SRTR were included in this analysis. Graft loss is defined as retransplantation or death during the 24 months post-transplant.</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The donors assigned to this group will receive standard of care of management of brain death donors in each organ procurement organization.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The donors assigned to this group would receive two RIPC interventions. The first one would occur immediately after brain death declaration and consent for organ donation. The second one would occur immediately before commencement of organ recovery. At each occasion RIPC would be induced by 4 cycles of mid-thigh inflation of tourniquet for 5 min followed by deflation for 5 minutes.
RIPC (Remote Ischemic Preconditioning): Remote Ischemic Preconditioning (RIPC) by Inflation of Pneumatic Tourniquet. The intervention will consist of tourniquet inflation on the mid-thigh for 5 minutes, followed by a deflation period of 5 minutes for a total of 4 cycles. The intervention will take place at two time points: First, after determination of brain death and consent for organ donation and again upon incision for organ recovery. The second intervention will occur in a manner identical to the first intervention but in the opposite limb.</description>
          </group>
        </group_list>
        <measure>
          <title>Graft Survival</title>
          <description>Kaplan-Meier estimates of 6, 12 and 24 months survival of all grafts</description>
          <population>All grafts transplanted from donors in the RIPNOD trial and in whom recipient records are available in SRTR were included in this analysis. Graft loss is defined as retransplantation or death during the 24 months post-transplant.</population>
          <units>percentage of all grafts</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="523"/>
                <count group_id="O2" value="489"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 months graft survival</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.3"/>
                    <measurement group_id="O2" value="94.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.8"/>
                    <measurement group_id="O2" value="92.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.2"/>
                    <measurement group_id="O2" value="87.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Log Rank</method>
            <method_desc>This is an unadjusted comparison</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Death-Censored Kidney Graft Survival at 6, 12 and 24 Months</title>
        <description>kidney graft survival censored for death with functioning graft</description>
        <time_frame>Kidney graft survival was monitored from transplant date until retransplantation or death up to 2 years as in SRTR data file October 2015</time_frame>
        <population>Included were kidneys transplanted alone or with pancreas. All kidney grafts transplanted from donors in the RIPNOD trial and in whom recipient records are available in SRTR were included in this analysis. Kidney graft loss is defined as loss of functioning graft or retransplantation during the 24 months post-transplant.</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>Kidneys in this group were recovered from donors in the No RIPC arm.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>Kidneys in this group were recovered from donors in the RIPC arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Death-Censored Kidney Graft Survival at 6, 12 and 24 Months</title>
          <description>kidney graft survival censored for death with functioning graft</description>
          <population>Included were kidneys transplanted alone or with pancreas. All kidney grafts transplanted from donors in the RIPNOD trial and in whom recipient records are available in SRTR were included in this analysis. Kidney graft loss is defined as loss of functioning graft or retransplantation during the 24 months post-transplant.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="247"/>
                <count group_id="O2" value="235"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Death censored kidney survival: 6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.2"/>
                    <measurement group_id="O2" value="99.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.5"/>
                    <measurement group_id="O2" value="96.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.4"/>
                    <measurement group_id="O2" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Log Rank</method>
            <method_desc>Results of adjusted Cox proportional hazard analyses for six month death-censored kidney graft survival are shown below</method_desc>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.19</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.04</ci_lower_limit>
            <ci_upper_limit>0.90</ci_upper_limit>
            <estimate_desc>The proportional hazard ratio favors RIPC group</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Recipient Survival</title>
        <description>Kaplan-Meier estimates of 6, 12 and 24 months survival of all recipients</description>
        <time_frame>Recipient survival was monitored from transplant date until death up to 2 years as in SRTR data file October 2015</time_frame>
        <population>All recipients of organs from donors in the RIPNOD trial and in whom recipient records are available in SRTR were included in this analysis</population>
        <group_list>
          <group group_id="O1">
            <title>No RIPC</title>
            <description>The recipients in this group received one or more organs from donors in the No RIPC arm of the RIPNOD trial.</description>
          </group>
          <group group_id="O2">
            <title>RIPC</title>
            <description>The recipients in this group received one or more organs from donors in the RIPC arm of the RIPNOD trial</description>
          </group>
        </group_list>
        <measure>
          <title>Recipient Survival</title>
          <description>Kaplan-Meier estimates of 6, 12 and 24 months survival of all recipients</description>
          <population>All recipients of organs from donors in the RIPNOD trial and in whom recipient records are available in SRTR were included in this analysis</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="494"/>
                <count group_id="O2" value="458"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recipient survival: 6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92"/>
                    <measurement group_id="O2" value="94.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.0"/>
                    <measurement group_id="O2" value="91.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.4"/>
                    <measurement group_id="O2" value="87.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.37</p_value>
            <method>Log Rank</method>
            <method_desc>This is an unadjusted comparison</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Adverse events to be collected were not identified or defined a priori. In donors, data were collected from enrollment to organ recovery; recipient data for DGF in kidney recipients were abstracted from transplantation to last follow up to 2 years in SRTR. Lack of information in SRTR precluded analyses regarding the severity of DGF. Submitted followup data was available at 6, 12 and 24 months in 97.5%, 75.5% and 38.8% of recipients, respectively. Updated SRTR recipient data has been requested.</desc>
      <group_list>
        <group group_id="E1">
          <title>No RIPC, Kidney Recipients</title>
          <description>Recipients in this group received kidneys from donors who did not receive remote ischemic preconditioning (No RIPC group)</description>
        </group>
        <group group_id="E2">
          <title>RIPC, Kidney Recipients</title>
          <description>Recipients in this group received kidneys from donors who received two RIPC interventions</description>
        </group>
        <group group_id="E3">
          <title>No RIPC, All Organ Recipients</title>
          <description>Recipients in this group received organs from donors who did not receive remote ischemic preconditioning (No RIPC)</description>
        </group>
        <group group_id="E4">
          <title>RIPC, All Organ Recipients</title>
          <description>Recipients in this group received organs from donors who received two RIPC interventions</description>
        </group>
        <group group_id="E5">
          <title>No RIPC, Donors</title>
          <description>Donors in this group did not receive remote ischemic preconditioning (RIPC)</description>
        </group>
        <group group_id="E6">
          <title>RIPC, Donors</title>
          <description>Donors in this group received two RIPC interventions</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="247"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="235"/>
                <counts group_id="E3" subjects_affected="81" subjects_at_risk="494"/>
                <counts group_id="E4" subjects_affected="54" subjects_at_risk="458"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="166"/>
                <counts group_id="E6" subjects_affected="14" subjects_at_risk="155"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Grafts lost</sub_title>
                <description>Number of grafts lost in all recipients</description>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="247"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="235"/>
                <counts group_id="E3" events="81" subjects_affected="81" subjects_at_risk="494"/>
                <counts group_id="E4" events="52" subjects_affected="52" subjects_at_risk="458"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Recipient Deaths</sub_title>
                <description>Recipient Deaths in all recipients</description>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="247"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="235"/>
                <counts group_id="E3" events="69" subjects_affected="69" subjects_at_risk="494"/>
                <counts group_id="E4" events="54" subjects_affected="54" subjects_at_risk="458"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Number of Donors from which no Organs recovered</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" events="8" subjects_affected="8" subjects_at_risk="166"/>
                <counts group_id="E6" events="14" subjects_affected="14" subjects_at_risk="155"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>DGF in kidney recipients</sub_title>
                <description>DGF defined as dialysis within the first week after kidney transplant</description>
                <counts group_id="E1" events="45" subjects_affected="45" subjects_at_risk="247"/>
                <counts group_id="E2" events="51" subjects_affected="51" subjects_at_risk="235"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Kidney rejection</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Kidney recipients that had an episode of rejection within the first 6 months</description>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="247"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="235"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="155"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="247"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="494"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="166"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="155"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>1) Bias from variation in the intervention between two sites; 2) Lack of blinding; 3) Inadequate data precludes analyses of ejection fraction; 4) Data on some of the other secondary outcomes were not available for all donors.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Baburao Koneru, MD, MPH</name_or_title>
      <organization>Rutgers-New Jersey Medical School</organization>
      <phone>(973) 972-9599</phone>
      <email>koneruba@njms.rutgers.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

